BDBM522084 US11155558, Compound 3h::US11155558, Compound 3p

SMILES CCCOc1ccc(S(=O)(=O)N2CCC([C@@H](CO[N+](=O)[O-])O[N+](=O)[O-])CC2)cc1-c1nc2c(CCC)cn(C)c2c(=O)[nH]1

InChI Key InChIKey=YGFFYOIIARLKDP-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 522084   

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 522084BDBM522084(US11155558, Compound 3p | US11155558, Compound 3h)
Affinity DataIC50: 1.00E+3nMAssay Description:The inhibition of recombinant human (rh) PDE5A by test compounds is measured in a radiometric assay based on Scintillation Proximity Assay (SPA) tech...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 522084BDBM522084(US11155558, Compound 3p | US11155558, Compound 3h)
Affinity DataIC50: 1.00E+4nMAssay Description:The inhibition of recombinant human (rh) PDE5A by test compounds is measured in a radiometric assay based on Scintillation Proximity Assay (SPA) tech...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent